GlassScriptPhysician profile
John W Duncan
NPI 1396844064
$13,456.98
in general payments reported to CMS, 2019-2025
51 companies · $1,559 in 2025
The $1,559 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,269 · 2020: $1,523 · 2021: $1,594 · 2022: $2,486 · 2023: $2,142 · 2024: $1,884 · 2025: $1,559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,584.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,380.00 | 2019-2025 | |
| Pfizer INC. | $1,360.67 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $957.51 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $944.18 | 2019-2024 | Xarelto |
| Abbott Laboratories | $875.47 | 2019-2025 | Jot Dx, Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Amgen INC. | $845.25 | 2019-2025 | Repatha, Repatha |
| Sanofi-Aventis U.S. LLC | $776.25 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $675.13 | 2021-2025 | Verquvo, Capvaxive |
| Heartflow, INC. | $541.15 | 2019-2025 | Ffrct |
| E.R. Squibb & Sons, L.L.C. | $532.98 | 2019-2025 | Camzyos, Eliquis |
| Amarin Pharma, INC. | $505.69 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $447.77 | 2019-2025 | Andexxa |
| Esperion Therapeutics, INC. | $370.18 | 2021-2025 | Nexletol |
| Novo Nordisk INC | $329.75 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $285.43 | 2019-2025 | Jardiance |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $266.35 | 2022-2024 | Corevalve Evolut R, Venaseal |
| Regeneron Healthcare Solutions, INC. | $185.79 | 2019-2024 | Evkeeza |
| Astellas Pharma US INC | $177.26 | 2019-2021 | |
| Tactile Systems Technology INC | $174.92 | 2019-2023 | Flexitouch Plus, Entre Plus |
| Boston Scientific Corporation | $142.59 | 2019-2025 | Watchman Flx |
| Kowa Pharmaceuticals America, INC. | $129.07 | 2019-2021 | |
| Angiodynamics, INC. | $99.09 | 2021-2022 | |
| Imperative Care, INC | $91.04 | 2025 | Symphony Catheter |
| Edwards Lifesciences Corporation | $90.85 | 2019-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Innovation Technologies INC | $86.90 | 2022-2023 | Irrisept |
| Cvrx, INC. | $84.01 | 2023-2024 | Barostim Neo System |
| Cashflow Solutions, LLC | $82.50 | 2023-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Impulse Dynamics (USA) INC. | $79.51 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $70.19 | 2025 | |
| Philips North America LLC | $69.60 | 2023-2024 | (Ck4) Mcot |
| Alnylam Pharmaceuticals INC. | $66.38 | 2019-2023 | Onpattro |
| Arbor Pharmaceuticals, INC. | $65.95 | 2019-2020 | |
| Gilead Sciences, INC. | $64.75 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $60.51 | 2021-2023 | Arcalyst |
| Scpharmaceuticals INC. | $58.62 | 2023-2024 | |
| Recor Medical INC | $55.18 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Kiniksa Pharmaceuticals International, Plc | $50.00 | 2024 | Arcalyst |
| Inspire Medical Systems, INC. | $46.11 | 2023-2024 | Inspire |
| Baxter Healthcare | $45.57 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Allergan, INC. | $39.96 | 2019 | |
| Chiesi USA, INC. | $36.09 | 2019-2020 | |
| Glaxosmithkline, LLC. | $34.28 | 2025 | Arexvy |
| Bridgebio Pharma, INC. | $29.24 | 2025 | Attruby |
| Vifor Pharma, INC. | $24.89 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $23.02 | 2023 | Inpefa |
| Genzyme Corporation | $20.54 | 2019 | |
| Lockedbrands | $18.59 | 2024 | |
| Portola Pharmaceuticals, LLC | $17.36 | 2019 | |
| Altathera Pharmaceuticals LLC | $15.60 | 2025 | Sotalol Hydrochloride |
| Siemens Medical Solutions USA, INC. | $14.49 | 2025 | Varian Treatment |
| Itamar Medical INC | $12.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Duncan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.